Cellectar Biosciences' PDC Delivery Platform May Advance Treatment of Multiple Myeloma

Company's platform could be transformative in treating cancer

Author's Avatar
Feb 13, 2017
Article's Main Image

This article was originally featured on CNA Finance.

Start a free 7-day trial of Premium Membership to GuruFocus.